Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/10
End: 06/30/11
Due: 06/30/12
Phase: N/A
Priority: Normal
Start: 02/28/10
End: 06/30/11
Due: 06/30/12
Phase: N/A
Priority: Normal
Start: 05/28/14
End: 10/31/16
Due: 10/31/17
Phase: N/A
Priority: Normal
Start: 03/31/14
End: 10/31/16
Due: 10/31/17
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Evaluation of Ciprofloxacin for Inhalation to Cystic Fibrosis Patients With P. Aeruginosa | NCT01090908 | Aradigm Corporation | user2@example.com | None | 2010-09-30 | 2011-06-30 | 2012-06-30 | - | - | 2025-07-14 |
| Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis "ORBIT-1" | NCT00889967 | Aradigm Corporation | user2@example.com | None | 2010-02-28 | 2011-06-30 | 2012-06-30 | - | - | 2025-07-14 |
| Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4) | NCT02104245 | Aradigm Corporation | user2@example.com | None | 2014-05-28 | 2016-10-31 | 2017-10-31 | - | - | 2025-07-14 |
| Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3) | NCT01515007 | Aradigm Corporation | user2@example.com | None | 2014-03-31 | 2016-10-31 | 2017-10-31 | - | - | 2025-07-14 |